Business Archives - Page 2 of 223 - Green Market Report

Debra BorchardtDebra BorchardtJuly 7, 2020
BeyondHello-1280x853.jpg

5min1190

Jushi Holdings Inc. (JUSHF) announced its financial results for the first quarter ending March 31, 2020, and pre-announced its second-quarter 2020 revenues. Total revenue for Jushi increased 43% sequentially to $8.6 million, while the company delivered a net loss for the quarter of $15.8 million. The net losses were down slightly from the fourth quarter’s net losses of $17 million.

The company attributed the increase in revenue to the acquisition of two medical marijuana dispensaries in Illinois, one of which began serving adult-use customers in March, and strong revenue growth at the Company’s BEYOND/HELLO stores in Pennsylvania.

“Our 43 percent quarterly revenue growth in the first quarter was driven by strong sales at our BEYOND/HELLO stores in Pennsylvania and the acquisition of two Illinois dispensaries,” said Jim Cacioppo, Chairman and Chief Executive Officer of Jushi. “I’m encouraged by the continued momentum we have seen coming out of our second-quarter results, where despite short-term headwinds such as the closure of two of our Philadelphia stores and several in-store initiatives aimed at prioritizing the health and safety of our employees, patients, and customers, we nearly doubled our sequential quarterly revenue growth rate to 74 percent with Q2 revenues of $15.0 million.”

Second Quarter Forecast

Jushi said that it expects to report total revenue of $15.0 million in the second quarter, an increase of 74% sequentially. The company also said that the annualized revenue run-rate for June 2020 of approximately $69 million, was a 38% increase over the March annualized run-rate and includes the negative impact of two closed Philadelphia stores due to break-ins at the end of May.  Adjusting for the closed stores, annualized revenue run-rate for June 2020 would have been approximately $78 million.

In addition to the second-quarter forecast, Jushi said it is also reaffirming its 2021 revenue guidance of $200 to $250 million. As of March 31, 2020, the company said it had $35.7 million of cash and cash equivalents as well as $13.6 million in short-term investments.

Management Comments

Mr. Cacioppo added, “While we are pleased with our topline results, we have also been implementing several cost reduction initiatives across our network of retail stores that are focused on strengthening our financial rigor and driving long-term profitability. These include the implementation of strategic purchasing practices, optimizing our labor model, improving our in-store product mix, creating additional targeted promotions, and further leveraging our beyond-hello.com online platform. While the impact of these changes are not significantly reflected in our Q1 results, I expect these changes to become more evident in the second quarter and as we enter into second half of the year.”

Mr. Cacioppo concluded, “We are also focused on further enhancing our customer experience at our existing dispensaries. During the second quarter, we relaunched Beyond-Hello.com which now features a vastly improved customer experience, real-time access to store inventory, and importantly online reservations. I can say with full confidence that the online roll-out has been a big success with online pre-ordering making up a very large percentage of our sales. We believe the online system has increased sales, operating efficiencies, and improved employee, patient, and customer safety. The BEYOND/HELLO retail brand has a reputation for providing a superior customer experience in Pennsylvania that we look to expand beyond the Commonwealth and into our Illinois, California, and Virginia markets.”


Sean HockingSean HockingJuly 6, 2020
shutterstock_784662001-1280x720.jpg

12min550

If you wish to re-publish this story please do so with the following accreditation
AUTHOR:  aBIZinaBOX Inc. CPAs – Jordan S. Zoot, CPA
PUBLISHER:  CANNABIS LAW REPORT

The Santa Barbara County Grand Jury issued its 2019-2020 Final Report on June 30, 2020. The last section of this report is devoted to the County’s actions relating to the cannabis industry. This last section of the Report is a scathing indictment of the manner in which greed for money and power influenced the governance of Santa Barbara County in its adoption of ordinances relating to cannabis.

The following is an introductory summary of the Report.

“The action taken by the Santa Barbara County Board of Supervisors to certify the development of a robust cannabis industry as the primary objective of the cannabis ordinances has altered the quality of life in Santa Barbara County, perhaps forever.

 “The fulfillment of that objective dictated the actions taken by the Board from the excessive allowance of licenses and acreage, creation of an unverified affidavit system, ignoring widespread odor complaints, not acknowledging the conflict between cannabis cultivation and traditional agriculture, to rejecting the environmentally superior alternatives of limited cannabis development.

 “Instead of a balanced approach carefully evaluating how the cannabis industry would be compatible, both as to amount of acreage and location, the Board simply opened the floodgates. These ordinances must be amended.”

This is the report of a civil grand jury. It is clear, however, that some of the matters discussed in this 26-page Report could well be the subject matter of a criminal grand jury investigation if these same matters were viewed a little differently. In fact, some of the matters described in this Report may well be under consideration by a criminal grand jury.

We are not writing about this Report because we have any particular interest in Santa Barbara County, or because some of the activities described in the Report may be criminal. We are writing about this Report because this Report should be mandatory reading for every member of every Board of Supervisors, City Council, Planning Commission, and Administrative Office that is involved in the considerations of that member’s governed community relating to the involvement of the community with the cannabis industry. This Report should also be mandatory reading for every California legislator and for every executive-level Administrator in any Administrative Department or Agency that has significant involvement with the cannabis industry.

California legalized medical cannabis in 1996 in Proposition 215. California legalized adult-use cannabis almost 20 years later in Proposition 64 – an initiative amendment to the California Constitution. Proposition 64 was ill-conceived and poorly drafted. See Keeping Proposition 215’s Promise. The California Legislature compounded the problems created by Proposition 64 with its attempt to impose regulation and taxation on a well-established industry by force of will. See, See Implementing Proposition 64. The most grievous error of the Legislature, however, is likely its creation of an administrative agency structure filled with intelligent and skilled administrators who were wholly lacking in an understanding of the existing industry as well as in the vision required to guide the conversion of the existing underground industry into a regulated industry. See Background California Cannabis Regulation.

The foundation for the chaos created by the people of California in Proposition 64 and the Legislature was passed on to the Cities and Counties of California much like a dangerous virus. Every City and County received some measure of encouragement, or pressure, from advocates, promoters, advisers, consultants, experts, and voters as well as a host of opportunists. Each had an opinion. Each had an agenda.

None of these individuals had a comprehensive and workable plan for how a particular locality could best fit into California’s regulated cannabis industry. The Legislature failed to design a comprehensive and workable plan for California’s regulated cannabis industry let alone explain how the well-established underground cannabis industry would transition into a regulated industry. As a consequence, most California Cities and Counties have some local version of the chaos that prevails throughout California in its cannabis industry.

Santa Barbara County is different from all other Counties. No other County is likely to have made the same errors as Santa Barbara. Most Cities and Counties, however, have succumbed to a greater or lesser degree to the encouragement, or pressure, that led Santa Barbara County to error so grievously. We recommend those individuals we describe above at least consider those paragraphs of the closing of the Report that follows and how the thoughts of the Santa Barbara County Grand Jury may apply in the locality with which they are involved.

“A more sobering realization for the Jury was that the governance in this matter took the form of some Supervisors aggressively pushing through their own agendas while other Supervisors meekly followed or resigned themselves to the inevitable.

 “Some senior staff in the office of the Santa Barbara County Chief Executive Office and the Santa Barbara County Planning and Development Department became cannabis advocates, losing their objectivity to the point of interfering in the responsibilities of independent agencies and elected officials.”

  “The Board of Supervisors rushed through the cannabis ordinances, ignoring the Santa Barbara County Planning Commission and staff recommendations on verification of applicants claiming eligibility to grow cannabis, to buffer distances for odor, and to not establishing cannabis as a compatible use that would allow for an analysis of compatibility with traditional agriculture. The actions of the Board resulted in the picking of winners and losers.

 “The Board of Supervisors used the mechanism of an Ad Hoc Sub Committee to craft the cannabis ordinances out of public view. These ordinances are now the cautionary tale for other counties in the State of California on what not to do.

 “The Ralph M. Brown Act codified as California Government Code 54950 et seq., declares as follows: 

‘In enacting this chapter, the Legislature finds and declares that the public commissions, boards, and councils and the other public agencies in this State exist to aid in the conduct of the people’s business. It is the intent of the law that their actions be taken openly and that their deliberations be conducted openly.’

The people of this state do not yield their sovereignty to the agencies which serve them. The people in delegating authority, do not give their public servants the right to decide what is good for the people to know and what is not good for them to know. The people insist on remaining informed so that they may retain control over the instruments they have created.’

“The Jury believes the Board of Supervisors, in their hubris, failed the people of Santa Barbara County. Now they must amend the cannabis ordinances to regain the people’s trust.” [Bold added.]

All of the tools exist under the existing laws of the State of California to create a legal cannabis industry that encompasses both medical and adult-use cannabis in which all businesses are in complete compliance with all applicable tax and regulatory responsibilities. The State of California, working with the purported leaders of the cannabis industry, has forcefully demonstrated that it does not know how to produce such a result. This result, if it is to be achieved, will be produced by the thoughtful efforts of the governance of California’s Cities and Counties.

The lesson all local leaders must take from Santa Barbara County is that the decisions each locality makes relating to cannabis must be based on a comprehensive understanding of the interests of the entire community with respect to California’s cannabis industry. Every resident of California is impacted to some degree by California’s cannabis industry. As a consequence, every resident has some interest in California’s cannabis industry. Responsible governance of each locality demands informed and thoughtful compromises relating to the best interests of the entire community in all things, including cannabis.

Cannabis is just another agricultural commodity. As California agricultural commodities go, it is not particularly important from a financial standpoint. As a consequence of greed, this agricultural commodity has received far more attention in recent years than can be justified. For political reasons, this agricultural commodity has long caused injuries to far more California residents than were justified. The legalization of adult-use cannabis in California has raised the financial stakes and imposed a far greater burden on knowledgeable and thoughtful local governance.

The story told in the Report illustrates how difficult it is for local governance to rise to the occasion in view lack of adequate support and guidance from the State. In this regard, some may see a parallel with the States and national leadership in connection with the COVID-19 crisis.

 


StaffStaffJuly 6, 2020
daily_hit004-1280x533.png

6min770

It’s time for your Daily Hit of cannabis financial news for July 6, 2020. 

On The Site

Fire & Flower 

The relationship between Fire & Flower Inc.  (OTCQX: FFLWF) and its strategic investor Alimentation Couche-Tard Inc. (OTC: ANCUF) had signaled that someday the convenience store chain Circle K would get involved with cannabis. It seems the day is getting closer as Fire & Flower announced the openings of its first two cannabis retail stores adjacent to Circle K locations in the province of Alberta. 

Fire & Flower’s plan is that it will gain from the high traffic at these Circle K locations that will be convenient for cannabis customers. The company said it believes it will maximize the benefit of the Spark Perks program and Spark Fastlane online ordering services at conveniently located stores. 

Havn Life 

Medical cannabis legalization is a fait accompli in thirty-three states and counting and eleven states have legalized recreational marijuana, suggesting a brighter horizon for other restricted plant medicines as well. Enter psychedelic mushrooms, otherwise known as Psilocybe spp., and Susan Chapelle, co-CEO of the newly-launched Havn Life, a company dedicated to developing a range of standardized, quality-controlled psilocybin products to be used by researchers. 

Chapelle (whose bio includes being the first female steel rigger in North America, a two-time elected politician, and boasts years spent lobbying for health policy change), launched Havn Life as part of a larger mission to build evidence-informed natural healthcare products that help people manage their own healthcare. 

In Other News 

Ayr Strategies 

Ayr Strategies Inc. (OTCQX: AYRSF) announced preliminary financial and operating results for the month of June and three months ended June 30, 2020. Revenue for June is expected to set an all-time monthly record at approximately $12.7 million, representing a 14% increase over the Q1 monthly average and a 46% increase over June 2019. Revenue for the second quarter is expected to be approximately $28.4 million, which represents a 15% decrease from the prior quarter due to COVID-related closures in April and May. 

“Despite the many challenges we faced during the second quarter, where our revenues fell essentially to zero at the beginning of April given the temporary regulatory restrictions in Nevada and Massachusetts, today’s preview of our Q2 2020 results shows our business is stronger than ever before,” said Ayr CEO Jon Sandelman. “In addition to increasing adjusted EBITDA and cash flow from operations for the quarter, we set monthly records in June for both revenue and adjusted EBITDA, as well as in income from operations.” 

Sunniva

Sunniva Inc. (OTCQB:SNNVF) said that its wholly owned subsidiary, 1167025 B.C. Ltd. (“1167025”) did not receive confirmation of the waiver of conditions on July 2, 2020 with respect to the previously announced sale of its property at Okanagan Falls, British Columbia, between 1167025 B.C. Ltd. and an independent real estate investment fund. As per the Sales Agreement, the failure to waive or fulfill any of the conditions will cause the contract to be terminated. On July 3, 2020, the Buyer advised the Company that it does not intend to proceed with the purchase of the property. 


Debra BorchardtDebra BorchardtJuly 6, 2020
CircleK.jpeg

5min6470

The relationship between Fire & Flower Inc.  (OTCQX: FFLWF) and its strategic investor Alimentation Couche-Tard Inc. (OTC: ANCUF) had signaled that someday the convenience store chain Circle K would get involved with cannabis. It seems the day is getting closer as Fire & Flower announced the openings of its first two cannabis retail stores adjacent to Circle K locations in the province of Alberta.

Fire & Flower’s plan is that it will gain from the high traffic at these Circle K locations that will be convenient for cannabis customers. The company said it believes it will maximize the benefit of the Spark Perks program and Spark Fastlane online ordering services at conveniently located stores.

“As we continue to build our relationship with Alimentation Couche-Tard, Fire & Flower is very pleased to be embarking on this initiative together,” shared Trevor Fencott, Chief Executive Officer of Fire & Flower. “We believe that combining convenient pickup locations with digital engagement offered by the Hifyre platform and Spark Perks program presents our customers with a differentiated value proposition in an increasingly competitive cannabis retail market. This approach to innovation in omnichannel and convenience-oriented cannabis retail differentiates Fire & Flower and positions us well to capitalize on both domestic and international opportunities.”

The company said the two stores in Calgary and Grande Prairie are expected to be the first of additional opportunities to co-locate cannabis retail stores in the future. The statement said that the co-located stores will be owned and operated by Fire & Flower and are separate from the adjacent Circle K in accordance with all applicable regulations. Alimentation Couche-Tarde said it has set its sights on the global expansion as new cannabis markets emerge.

In August 2019, Fire & Flower closed a strategic investment by Alimentation Couche-Tard. The company noted in its filing statement that this transaction allowed for Couche-Tard to obtain a controlling interest and provides more than $380 million of growth capital for global expansion. It provided significant, new possible commercialization and leadership opportunities for Fire & Flower’s proprietary Hifyre digital platform and access to Couche-Tard’s leadership team.

Convenience Stores

It has been argued that if cannabis is rescheduled and treated like alcohol or tobacco, cannabis products could end up in convenience stores. Products for adults over 21 like alcohol and tobacco are already sold in the convenience store model, so adding cannabis to the mix isn’t a stretch as long as the product is fully legal. A few cannabis companies had already begun to establish such relationships, if mostly behind closed doors.

The cannabis industry doesn’t want to discuss such an outcome as it would destroy the need for dispensaries. Plus, convenience stores typically only carry products from a small group of very connected consumer package goods companies. A look at the beer offerings demonstrates that only a handful of choices are offered. These beers, not necessarily considered the best the industry has to offer, are sold at high volumes.

This is the fear for many in the cannabis industry. The convenience stores may only carry a few big-name brands, that may not be the best cannabis, but is scalable cannabis. The winners of all this volume business will only be the ones picked by the convenience store chain. Cannabis brands will have to decide if they want to be a craft business or a volume business like Budweisers.

 

 

 


Julie AitchesonJulie AitchesonJuly 6, 2020
Havn.jpg

5min4060

Medical cannabis legalization is a fait accompli in thirty-three states and counting and eleven states have legalized recreational marijuana, suggesting a brighter horizon for other restricted plant medicines as well. Enter psychedelic mushrooms, otherwise known as Psilocybe spp., and Susan Chapelle, co-CEO of the newly-launched Havn Life, a company dedicated to developing a range of standardized, quality-controlled psilocybin products to be used by researchers.

Chapelle (whose bio includes being the first female steel rigger in North America, a two-time elected politician, and boasts years spent lobbying for health policy change), launched Havn Life as part of a larger mission to build evidence-informed natural healthcare products that help people manage their own healthcare. 

Developing a reliable, safe, standardized supply of psilocybin, which does not currently exist, is a central part of this broader vision. “A concern that all companies must grapple with as we look to the future of psychedelic medicines is the future of the supply chain,” Chappelle explains. “Havn Life is developing two labs in the South Campus of The University of British Columbia (UBC), where we will develop methodology for growing and extracting Psilocybe spp. These compounds will be available to academics studying psychedelics until policy becomes informed by evidence, and the market opens up to these compounds as approved medication.” But Susan Chapelle and her team do not intend to stop there, she states. “Havn Life is diversified and looking at other psychoactive compounds for use in Natural Health products to get to market using evidence-informed formulations derived from fungus and plants.”

Havn Life’s supply development won’t only benefit their own bottom line, however. “Havn Life is developing a reliable and safe supply chain of psychedelic compounds,” Chapelle says, “an essential component that will enable other companies to move to human clinical trials.” When I asked about the ways in which Havn Life is navigating the regulatory landscape as part of this endeavor, Chapelle informed me that “psilocybin is currently scheduled as a restricted compound by most governments. It is a controlled compound in Canada; however, both animal and human trials can be conducted through an application process to Health Canada. There is still a hangover effect from the ‘war on drugs,’ but ultimately the regulators must absorb the evidence from five decades of clinical research, most of which is peer-reviewed and published.”

Chapelle is unfazed regarding other potential obstacles to realizing her team’s vision for Havn Life. “The amount of collective knowledge and the fact that we are all trailblazers that have worked in nascent industries such as cannabis, technology, and formulations is such an incredible benefit. We have an ability to look at obstacles as challenges to be solved.” With the partnership with the University of British Columbia firmly in place and a diverse team of dedicated professionals, Havn Life’s mission appears anything but impossible. “Civilization has been enjoying mushrooms in both cultural ceremonies and for recreational purposes for eternity,” Chapelle asserts. “Access to a safe, properly dosed, standardized drug supply is long overdue.”

 


StaffStaffJuly 6, 2020
shutterstock_1387048082-scaled.png

8min1791

Editors Note: This is a guest post.

Cannabis and its derivative products are all the rage right now. State after state legalizes its recreational use and dispensaries all over the country are making loads of money. The medicinal aspects of the plant are also heavily taken advantage of by big pharmaceutical companies, with new, branded drugs being released with cannabis as their primary component. 

Although Canada is at the forefront of the legalization battle, having fully legalized all uses of the plant back in October 2018, the United States is not lagging behind. One of the better examples of this in Nevada, where after the passing of a bill allowing the sales of recreational pot by any licensed dispensary, free delivery of cannabis in Las Vegas drew so many customers in, that many of these businesses were running out of drivers! 

These developments naturally make investors around the world question whether investing in cannabis-related stocks is worthwhile. The weed market is very young, and therefore highly volatile, and therefore susceptible to many ups and downs in the nearest future. It will take an additional couple of years for it to stabilize, which is something you need to keep in mind when planning out your investments

The general trend seems to be that it will continue to grow, as proven by the continuous passing of legislation in countries around the world, liberalizing the restrictions on the stuff. This allows entrepreneurs and investors alike to get creative with their money and come up with exciting new ways to consume and make use of cannabis. 

Experts predict that by 2022, the marijuana market will reach $32 billion — that leaves plenty of room for improvement and growth, making weed stocks a perfectly viable option for investments. You will find the most powerful and stable publicly traded cannabis companies below. 

Canopy Growth Corporation

This Canadian company is a true cannabis giant — back in 2014, it became the first company of its kind to be publicly traded. Back then, it was listed on the Toronto stock exchange and made its way to the NYSE in May 2018. 

Canopy Growth (NYSE:CGC) made the headlines in 2018 when Constellation Brands bought $4 billion worth of their stock. They are an alcohol importer, so you can be sure that there’s a plan of producing branded marijuana-infused beverages in the works. 

Moreover, Canopy was the first Canadian producer to export their dried marijuana to Germany, making it a truly intercontinental corporation. They continue their operations on European soil through a wholly-owned subsidiary that distributes Canopy products to German pharmacies. 

As of recently, Canopy has been aggressively increasing its footprint in the American market, most notably through striking a deal with Acreage Holdings (a US-based major distributor), allowing it to secure a huge market share in the US, by far the largest cannabis market in the world. 

Canopy Growth is by far the most secure option to invest in, as they have proven their global ambitions and increased scope of their operations year after year since its inception back in 2013. 

Tilray 

Similarly to Canopy, Tilray is also one of the largest cannabis-producing corporations in the world. Based in the United States, its scope is even larger than that of Canopy Growth, with Tilray owning subsidiaries all over the globe — they’re exporting to places like Chile and Argentina, but also plenty of European countries, such as Ireland and Switzerland. Tilray has also opened a licensed production facility in Portugal, the only North American company to produce cannabis-based products in the EU. They can be found in pharmacies in most European countries. 

It is also worth noting that while the Asian cannabis market is largely untapped due to extremely strict regulations of the plant in those regions, Tilray has managed to open up limited facilities in South Korea and Japan — as the trend of cannabis laws being liberalized all over the globe continues onto Asia, Tilray will be ready for it, way ahead of other cannabis enterprises. 

If you need any more convincing of Tilray’s might and the influence it wields over the global cannabis industry, there is no better example of it than the fact that its CEO, Brendan Kennedy has become the first-ever marijuana billionaire, with his net worth being estimated at around $2.4 billion. 

The Choice is yours 

Investing large amounts of money into a volatile market should always be done with extreme caution. This is a move that needs to be thought through. Should you invest in one of the big boys, like Tilray and Canopy Growth, or move your money towards a smaller, but more exciting enterprise, such as the various local dispensary chains that are literally popping up like mushrooms after heavy rainfall? 

The choice belongs to you. As for the industry giants, it might be more reasonable to buy Canopy Growth stock, as it is still less developed than Tilray, and their potential is still largely untapped, making it the more exciting option of the two. 

 


StaffStaffJuly 3, 2020
flag.jpg

5min5400

This year the 4th of July falls on a Saturday and that would normally mean big parties and celebrations. However, with the COVID-19 pandemic in full force, fireworks displays have been canceled and beaches closed in many states. The front page of the Houston Chronicle asked everyone to just stay home. What’s open? Dispensaries.

Cannabis software company Akerna (NASDAQ:KERN) said that it expects the essential services of cannabis will continue to benefit as other businesses struggle to open.

“For the first time in the past five years the 4th of July falls on a Saturday,” said James Ahrendt, Business Intelligence Architect, Akerna. “We anticipate sales will start to increase Thursday, July 2, with an 80% increase over daily averages culminating in an 87% increase over average daily sales over the holiday weekend.”

In 2019, when the 4th of July fell on a Thursday, there was a spike in sales the preceding Friday and Saturday, as well as the day leading up to Independence Day. However, not much change in sales the day of.

Sales expectations for the 4th of July. Akerna anticipates:

  • An 87% increase over average daily sales 7/2-7/4
  • Sales will start to increase July 2, with 80% (1.8X) increase on daily average sales for 2020
  • Friday, July 3will be the highest-grossing day of the year surpassing 4/20, which fell on a Monday. Modeling shows July 3 sales will be 100% (2X) increase on daily average sales for 2020.
  • Saturday, July 4, will see elevated sales, similar to Thursday, with 80% (1.8X) increase on daily average sales for 2020

Top Sellers for the 4th of July:

  • Flower 45% of sales
  • Cartridges / Pens 35%
  • Concentrates 11%
  • Edibles 9%

Spending:
The National Retail Federation expects 76% of consumers plan to celebrate Independence Day. Those who do have plans for the holiday expect to spend $76.00 on average in celebration of the 4th of July. The average cannabis order total will be close to $100 and an increase of $11 than the avg order total for all other days this year, which range in the area of $87.12 nationally.

On the Grill:
Historically people spend more than $371 million on chicken during the two weeks leading up to the July 4 weekend, which amounts to about $37 million a day. Cannabis sales are expected to reach over $260 million in three days, which is about $86 million a day.

Historic July 4th Meat Sales:

  • Chicken $371 million
  • Pork $271 million
  • Shrimp $85 million
  • Salmon $48 million


Noemi GonzalesNoemi GonzalesJuly 3, 2020
792399-v0_5-GMR-BC-FB.png

5min730

Ganja Yoga: A Practical Guide to Conscious Relaxation, Soothing Pain Relief, and Enlightened Self-Discovery” by Dee Dussault and Georgia Bardi 

 Another amazing combination at hand today – Yoga and Cannabis.

“Ganja Yoga: A Practical Guide to Conscious Relaxation, Soothing Pain Relief, and Enlightened Self-Discovery: by authors Dee Dussault and Georgia Bardi combine these two amazing topics into one very useful book.
Let’s downward-dog our way into this one, shall we?

-Topic Focus-

The relationship between cannabis use and performing Yoga is not new and these two wonderful authors do a fantastic job of breaking down the history of how these two are connected, the mental and physical benefits, the science related to them, the best strains to combine while engaging in Yoga, and so much more.

Ancient Yogis utilized marijuana for the spiritual benefit and this aspect of the topic is covered in-depth in this book as well.

The world is rapidly becoming more and more accepting of cannabis use and we are beginning to see it appear in a wider variety of activities so it is fun and fascinating to learn how we can combine a healthy activity with our favorite flower.

About the Author

Let’s take a look at where exactly the expertise offered in “Ganja Yoga” comes from with the authors.

Author Dee Dussault is a certified Yoga instructor, sexuality coach, and possesses a passion for healing, cannabis, mindfulness, and sharing the benefits from these topics with as many people as possible. She runs “Ganja Yoga” which is also a website and service that guides people on how to better live using cannabis and Yoga.

If you are interested in learning more about author Dee Dussault, her team, or their Ganja Yoga teachings then you can find them here:

https://www.ganjayoga.com/about

-Reading Experience-

“Ganja Yoga: A Practical Guide to Conscious Relaxation, Soothing Pain Relief, and Enlightened Self-Discovery” strikes that fine balance of being incredibly informative, maintaining an interesting flow, while also conveying the authors own style and personality.

Methods of cannabis consumption, purchasing marijuana tips, the history of cannabis and Yoga, and so much more are fluidly blended in this book that flies by despite being nearly 300 pages.

The amount of connection between Yoga and cannabis use is surprising and this book helps to further ignite the reader’s own interest in Yoga and to be more mindful of how we can combine medicating with cannabis or using it recreationally while becoming healthier with Yoga.

-Summary-

Yoga and Cannabis use are a match made in heaven and “Ganja Yoga” helps us laypeople who lack the expertise to better understand how to maximize the benefits of combining these two wonderful things.

It is interesting to explore the history of how ancient Yogis utilized Cannabis nad it adds serious value to your life by helping you to put together an action plan to increase your quality of life by more intelligently leveraging Cannabis and Yoga in your life.

If you’re looking to get started down the path of better health and tranquility through Ganja Yoga then you can begin by getting your copy here:

https://www.amazon.com/Ganja-Yoga-Relaxation-Enlightened-Self-Discovery/dp/0062656848/ref=sr_1_6?dchild=1&keywords=stoner+meditation&qid=1593025426&s=books&sr=1-6

 


StaffStaffJuly 3, 2020
woman-3.jpg

8min3540

Editors Note: this is a guest post.

Cannabis can be used in countless ways. It relieves stress, chronic pains, and a wide plethora of other conditions. Besides medicinal uses, people consume marijuana to relax or help them fall asleep. 

The great thing about the times we live in is that it’s an era of marijuana legalization and getting a hold of exactly the type of weed you’re after is easier than ever. If you don’t believe that to be true and you’re in Nevada, just look up Las Vegas Dispensaries and large cities in other legal states are increasingly becoming hotspots for cannabis enthusiasts and entrepreneurs.

One of the most popular misconceptions about cannabis is that it turns you into a lazy, unmotivated couch potato. While it certainly rings true for some of the strains out there, it is worth remembering that there are others, which can fire up your imagination, breathe life into conversations, and expedite the creative process. 

The trick lies in knowing which strain to choose for those particular moments when you are trying to get in the right headspace to get that creative spark going. If that’s what you’re after, be sure to check out one of these six strains listed below. 

Jack Herer 

Named after one of the greatest cannabis rights activists in history, this strain will elevate your mind up to a point where you will be spitting out new ideas one after another. 

Besides the euphoric effect, Jack Herer is a treat to smoke due to its fruity, peppery flavour. Whether you’re enjoying it in the form of a joint or bong hit, it will pack a punch that you will not soon forget. Another advantage is that contrary to other popular strains, Jack Herer leaves you clear-headed without the all-too-familiar dazy feeling one might get after the high goes away. 

Jack Herer was recognized for its inspiring qualities by the international community of enthusiasts, having won numerous awards for its potency and creativity-friendly effects. 

Berry White 

Also known as Blue Widow or White Berry, this particular strain of cannabis is a sativa-dominant hybrid, which already gives away that you’re in for an energizing kick! 

A hit of Berry White will definitely inspire many creative endeavours. Additionally, the high is very balanced, eliminating the risk of increased anxiety and paranoia which is often associated with sativa-dominant hybrids. 

Berry White will leave you energized and ready to create, while keeping your mind focused instead of going all over the place and ruining your experience. 

Tangerine Dream 

Many people in the community will refer to it by Tangie, but regardless of the name it goes by, this strain is recognized and appreciated by artists and other creative individuals. Its main benefits include a long-lasting high — an uplifting experience with just enough relaxing qualities to keep you in the zone for a while.  

What makes Tangerine Dream really stand out though, is its refreshing aroma and an unmistakable, fruity flavor. Aptly named after tangerines, this strain really does bring to mind those delicious citruses. 

Whether you’re a musician, writer, or any other type of a creative soul, Tangerine Dream is definitely a strain that should end up in your stash one day. 

Jillybean 

An incredibly powerful strain with a non-threatening name, Jillybean is the queen of fun. The effects are almost immediate, and the most reported feeling after consuming it is overwhelming bliss and euphoria. 

Jillybean is a favorite of creatives and social butterflies alike, as it enhances the quality of your social interaction and increases empathy for fellow human beings. You can recognize it by the strong aroma of orange with a hint of mango — it’s similar to Tangerine Dream in this aspect. 

This particular creativity-enhancing strain works especially well if you’re in need of a long, uninterrupted session of brainstorming and piecing together your ideas, especially if you’re participating in a collaborative effort!

Kali Mist 

If your creativity is hindered by a lack of energy, then this strain might just be exactly what you’re looking for to boost you up and get those creative juices flowing at a higher rate. 

The perfect pick-me-up strain, Kali Mist’s rejuvenating qualities were oftentimes hailed as “psychedelic” by users, due to its focus-enhancing and ego-crushing abilities. Kali Mist is the perfect choice when you need to open up your mind to new, challenging ideas. 

Be wary of its side effects though — if you’re planning a longer session in Kali Mist’s company, make sure you have enough water to stay hydrated, as this strain is infamous for causing intense cottonmouth in some users. 

LSD 

Although its name may suggest otherwise, the LSD strain won’t make hallucinate or trip out like you would on psychedelics. The similarity lies in the euphoric feeling that comes with smoking this type of cannabis. 

Just like all of the strains listed above, LSD is also a sativa-dominant hybrid, but the characteristic attribute that sets it apart from the rest is the strong, but not overwhelming body high that accompanies the energizing effects. 

 


Video StaffVideo StaffJuly 3, 2020

4min3560

It’s a shortened trading week as markets are closed on Friday to celebrate the Fourth of July. The good news is that 2020 is half over.

 

Despite the continued pressure on cannabis stocks, investors continue to pour money into the industry. The companies most favored are those with consistent and reliable sources of revenue. This week Innovative Industrial Properties, Inc. (IIP) (NYSE:IIPR)  priced its underwritten public offering of $225 million. The deal is expected to close on or about July 2, 2020. The underwriters also have a 30-day option to purchase up to an additional 402,504 shares of its common stock.

 

GrowGeneration Corp. priced an underwritten public offering of roughly $42 million and that’s up from the originally planned $35 million.

 

Bhang reported that it had revenue of $4.7 million in 2019, but net losses of $15 million. 

 

There was also a lot of news from the pharma side. GW Pharmaceuticals outlined its plans for its other cannabis drug Sativex. It has a strategy to use the drug as a treatment for MS Spasticity. PTSD and spinal cord injury.

 

Zynerba unfortunately had to report that its trial for its Zygel drug as a treatment for Fragile X failed to produce the necessary threshold for positive results. 

 

Cresco Labs Inc. and Innovative Industrial Properties, Inc. (IIP) have closed on the acquisition of a property in Massachusetts with a leaseback agreement. The property is valued at $7.8 million and is the fifth such deal the two have done.

 

Harborside said it won’t be able to file its financial reports on time. A cease trade order is expected until the company can get those results published.

 

And finally, HBO Max has become the latest production company to use cannabis products as a marketing tool for an animated show called Close Enough that will begin streaming on July 9. The company is partnering with Sunderstorm’s Kanha Cannabis Infused Gummies and online cannabis marketplace Eaze to launch a collection of character-inspired CLOSE ENOUGH edibles. 



About Us

The Green Market Report focuses on the financial news of the rapidly growing cannabis industry. Our target approach filters out the daily noise and does a deep dive into the financial, business and economic side of the cannabis industry. Our team is cultivating the industry’s critical news into one source and providing open source insights and data analysis


READ MORE



Recent Tweets

@GreenMarketRpt – 2 days

⁦@KushCo_Holdings⁩ $KSHB Revenue Misses Analysts Estimates As It Drops 46%

@GreenMarketRpt – 2 days

COVID Recovery Has Been Anemic a new report from @N1-Consulting #GMR…

Back to Top

You have Successfully Subscribed!